Over 200 biopharma investors urge EU governments to strengthen Europe's life-science sector
read at Endpoints ↗RegulatoryNeutral
More than 200 biopharma investors and companies have signed an open letter addressed to EU member states, calling for action to improve Europe's life‑science sector.
The signatories argue that Europe needs stronger support to remain competitive, especially as U.S. pricing pressures intensify.
They ask governments to implement policies that boost the sector's growth and innovation, though the letter does not specify particular measures.
The appeal was made public on a Friday, highlighting a coordinated industry effort to influence European health‑policy decisions.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “EU lobby urges member states to improve Europe’s life sciences sector”
read at Endpoints ↗81 words · retrieved Jul 1
comments(0)
5-min edit window · permanent after that